Tradestie Institutional Equity Comparison Engine

TLPH vs IRWD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IRWD Overall Edge

IRWD Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ironwood Pharmaceuticals, Inc. - Class A (IRWD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while TLPH counters with relative strength in Valuation. Fundamentally, TLPH trades at 1.0x Forward P/E with -1474700.0% operating margin (+0.0% YoY revenue) versus IRWD at 12.3x Forward P/E and 62.9% operating margin (+9.0% YoY). In options structure, TLPH sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against IRWD sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TLPH
TLPH 1.0x vs IRWD 12.3x Fwd P/E
Growth & Margin Winner IRWD
Op Margin -1474700.0% vs 62.9% ยท YoY +0.0% vs +9.0%
Momentum & Technical Winner IRWD
1Y -18.0% vs +44.2% ยท 52W Pos 20% vs 68%
Options & Structure Winner IRWD
UNCLASSIFIED (100th %ile IV) vs CONSOLIDATION (6th %ile IV)
TLPH NASDAQ
Talphera, Inc. Common Stock
Pharmaceutical Preparations
$0.86
-4.98% 1D
Market Cap $53.7M
1M Return -20.29%
1Y Return -18.01%
Forward P/E 1.0x
Unified AI Score
37.1 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 59.0
IRWD NASDAQ
Ironwood Pharmaceuticals, Inc. - Class A
Pharmaceutical Preparations
$4.86
+0.62% 1D
Market Cap $802.9M
1M Return +38.86%
1Y Return +44.21%
Forward P/E 12.3x
Unified AI Score
35.0 / 100 SELL
Tech 50.0 Fund 34.0 Flow 66.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TLPH -18.01% IRWD +44.21% Spread: +62.22 pp (IRWD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TLPH TTM Op. Margin: -1474700.0% IRWD TTM Op. Margin: 62.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TLPH vs IRWD. Trailing 12-month operating profitability (TLPH -1474700.0% vs IRWD 62.9%) and valuation multiples (TLPH 1.0x vs IRWD 12.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TLPH (4) vs IRWD (6)
Institutional Metric TLPH IRWD Criterion Row Winner
Market Capitalization Scale $53.7M $802.9M Larger Scale IRWD
Trailing P/E Ratio Valuation 1.0x 5.4x Lower Multiple TLPH
Forward P/E Ratio Valuation 1.0x 12.3x Lower Multiple TLPH
Revenue Growth (YoY) Growth +0.0% +9.0% Higher Growth IRWD
Operating Margin (TTM) Profitability -1474700.0% 62.9% Higher Margin IRWD
Net Profit Margin Profitability 0.0% 37.4% Higher Margin IRWD
Return on Equity (ROE) Capital Efficiency -143.4% -574.7% Higher ROE TLPH
52-Week Range Position Momentum 20% ($1โ€“$2) 68% ($3โ€“$6) Stronger Trend IRWD
Beta / 30D Volatility Risk Regime 1.11ฮฒ ยท 58% Vol 1.37ฮฒ ยท 54% Vol Lower Realized Risk IRWD
Unified Institutional Score Composite Signal 37.1 / 100 (SELL) 35.0 / 100 (SELL) Higher Composite TLPH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TLPH vs IRWD Buy Guide
TLPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live TLPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IRWD CONSOLIDATION
134d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live IRWD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TLPH nor IRWD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.